Skip to main content
Clinical Trials/NCT02263261
NCT02263261CompletedNot Applicable

Reconstructive, Aesthetic and Patient Reported Outcomes Associated With the Use of Flex HD Pliable, Perforated Human Acellular Dermal Matrix in Implant-Based Breast Reconstruction: A Pilot Study

Musculoskeletal Transplant Foundation2 sites in 1 country40 target enrollmentStarted: March 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
2
Primary Endpoint
Types and incidence of complications

Study Overview

Brief Summary

Use of a HADM and implant in post-mastectomy breast reconstruction.

Detailed Description

This is a prospective, single-site pilot study in which outcomes associated with the use of Flex HD® Pliable™ Perforated, Human Acellular Dermal Matrix and an implant which are used in post-mastectomy breast reconstruction will be obtained. The data collected will include reconstructive outcomes, aesthetic outcomes and patient-reported outcomes in order to ascertain advantages and disadvantages of using this particular HADM in post-mastectomy breast reconstruction.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Scheduled to undergo a single or two-stage, tissue-assisted, implant breast reconstruction
  • •Mastectomy may be unilateral or bilateral, prophylactic or therapeutic
  • •Skin incision may be skin sparing, or nipple-areolar sparing
  • •Have signed written, informed consent
  • •Be at least 18 years of age

Exclusion Criteria

  • •Patients undergoing autologous breast reconstruction
  • •Patients undergoing breast reconstruction following complications of breast augmentation, mastopexy, breast reduction, or breast conservation surgery (lumpectomy)
  • •Patients undergoing reconstruction after previously failed attempts at reconstruction
  • •Patients undergoing autologous breast reconstruction in conjunction with a tissue expander (such as a latissimus dorsi flap, DIEP flap)
  • •There will be no exclusions based on race or ethnicity
  • •BMI > 40
  • •Previous Radiation Treatment. Note: Post-operative radiation treatment does not exclude subjects from study continuation once enrolled.

Arms & Interventions

Flex HD Pliable Perforated HADM

Other

Single Arm

Intervention: Flex HD Pliable Perforated HADM (Other)

Outcomes

Primary Outcomes

Types and incidence of complications

Time Frame: 6 months post reconstruction

Documentaiton of any medical and/or surgical problem requiring treatment that arises as a result of the reconstruction procedure

Secondary Outcomes

  • Aesthetic Outcomes(6 months post reconstruction)
  • Patient-Reported Outcomes(6 months post reconstruction)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials